• Drug Price Control Orders (DPCO) 2013 categorize drugs into scheduled and non-scheduled formulations.

• The National Pharmaceutical Pricing Authority (NPPA) annually revises the ceiling prices of scheduled medicines based on the Wholesale Price Index (WPI).

• Recent media reports falsely claimed a significant 12% hike in medicine prices starting in April 2024.

• However, for 2023, WPI (Wholesale Price Index) increased by a negligible 0.00551%, resulting in no change in ceiling prices for 782 medicines up to 31.3.2025.

• Fifty-four medicines may see a small hike of Rs. 0.01, but companies may choose not to implement it.

• Manufacturers of non-scheduled formulations cannot increase MRP by more than 10% in the preceding 12 months under DPCO 2013.

Click here to read more